Article
[Usefulness of thiopurine methyltransferase polymorphism study and metabolites measurement for patients treated by azathioprine].
La Revue de medecine interne - 1 Jun 2018
Guillotin V, Galli G, Viallard J-F
Abstract excerpt
Azathioprine is widely used in internal medicine and frequently implicated in occurrence of adverse events. Among these adverse events the bone marrow suppression, a dose-related one, is the most serious because of is potential morbidity and mortality. Severe myelosuppression, associated with abnormal AZA metabolism, is linked to the thiopurine methyltransferase (TPMT) genetic polymorphism that results in a high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
